Delivery Order SPE2DB22D3501-SPE2DB26FTF80
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram quantity, valued at $5,766.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram format, with a ceiling value of $2,046.89. This competitively awarded, firm fixed-price contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order carries...
- The Defense Logistics Agency awarded a delivery order valued at $7,101.39 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% cream in 60-gram quantities. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,139.48 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price, non-set-aside contract with a completion date of September 16, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,381.02 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in a 60-gram quantity. This competitively awarded, firm fixed-price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a contract ceiling value of $1,310.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a ceiling value of $6,776.02 and an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a Delivery Order (4568090195) to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,480.01 under firm fixed pricing terms, with performance to be completed by May 1, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $3,358.40 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The product will be performed at AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTF80Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,076.23 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram formulation. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by October 27, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under its larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order represents a typical transaction under AmerisourceBergen Drug Corp's comprehensive $999.99 billion IDC with the Defense Logistics Agency's Troop Support Medical, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. The company's contract portfolio with DLA demonstrates extensive capability in supplying brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The competitive, non-set-aside nature of this award and its firm fixed pricing reflect the contractor's established position as a critical vendor meeting federal procurement requirements for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 10/24/25 |